Blood and gut clues may flag pancreatic cancer risk early

This observational study is investigating whether certain blood markers and gut microorganisms can help identify people with chronic pancreatitis who are at higher risk of developing pancreatic cancer. Researchers will compare healthy individuals, those with chronic pancreatitis, and those with newly diagnosed pancreatic cancer, tracking changes over time. Participants will provide blood and stool samples, and those with chronic pancreatitis will be followed every 6 to 12 months. The study does not assign any treatment; its goal is to improve future risk assessment methods.